Ahead of a change in leadership at the top after the upcoming annual general meeting, in interviews with news agencies Bayer is dropping hints in dribbles about future...
15.05.2019
- Bionure, a Barcelona, Spain-based clinical stage R&D company specialized in the treatment of neurodegenerative diseases, has appointed Lucia Septien as chief medical officer (CMO)...
12.04.2016
- Allergan Pharmaceuticals International, a wholly owned subsidiary of Ireland-based Allergan, has entered a definitive agreement with British biotech firm Heptares to license...
07.04.2015
- Belgium's UCB has agreed to sell its established brands in India, including its franchises in the areas of allergies and respiratory disorders, to Dr. Reddy's Laboratories for INR...
10.04.2013
- GlaxoSmithKline, Britain's biggest drugmaker, is placing a small but important bet on a new way of treating diseases by targeting electrical signals in the body. The company said...
23.11.2010
- Evotec has signed an agreement with Merck KGaA, Darmstadt, Germany, to develop pre-clinical candidates for an undisclosed neurological disease. Evotec will provide drug discovery...
